UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Cost-effectiveness of Screening for Chronic Hepatitis B Infection in the United States

Clinical infectious diseases, 2011-06, Vol.52 (11), p.1294-1306

2011

Volltextzugriff (PDF)

Evolution of Treatment-Emergent Resistant Variants in Telaprevir Phase 3 Clinical Trials

Clinical infectious diseases, 2013-07, Vol.57 (2), p.221-229

2013

Volltextzugriff (PDF)

Hepatitis C Virus Coinfection and Superinfection

The Journal of infectious diseases, 2007-02, Vol.195 (4), p.519-524

2007

Volltextzugriff (PDF)

Nucleoside Analogues and Mitochondrial Toxicity

Clinical infectious diseases, 2004-04, Vol.38 (8), p.e79-e80

2004

Volltextzugriff (PDF)

Hepatitis C Virus Cure Is the Start of the End for Patients With Advanced Fibrosis/Cirrhosis

Clinical infectious diseases, 2020-12, Vol.71 (10), p.2730-2731

2020

Volltextzugriff (PDF)

Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study

Clinical infectious diseases, 2018-09, Vol.67 (7), p.1010-1017

2018

Volltextzugriff (PDF)

Immunogenicity and Safety of Hepatitis B Virus (HBV) Vaccine With a Toll-Like Receptor 9 Agonist Adjuvant in HBV Vaccine-Naïve People With Human Immunodeficiency Virus

Clinical infectious diseases, 2023-08, Vol.77 (3), p.414-418

2023

Volltextzugriff (PDF)

Hepatitis C Virus (HCV) Quasispecies Complexity and Selection in HCV/HIV-Coinfected Subjects Treated with Interferon-Based Regimens

The Journal of infectious diseases, 2010-03, Vol.201 (5), p.712-719

2010

Volltextzugriff (PDF)

Liver Fibrosis Progression and Mortality in Hepatitis B– and C–Coinfected Persons Treated With Directly Acting Antiviral Agents: Results From ERCHIVES

Clinical infectious diseases, 2020-07, Vol.71 (3), p.664-666

2020

Volltextzugriff (PDF)

GB Virus C (GBV-C) Infection in Hepatitis C Virus (HCV)/HIV–Coinfected Patients Receiving HCV Treatment: Importance of the GBV-C Genotype

The Journal of infectious diseases, 2006-08, Vol.194 (4), p.410-419

2006

Volltextzugriff (PDF)

Cost-effectiveness of Screening for Chronic Hepatitis C Infection in the United States

Clinical infectious diseases, 2013-05, Vol.56 (10), p.1382-1393

2013

Volltextzugriff (PDF)

Improvement in Hepatic Fibrosis Biomarkers Associated With Chemokine Receptor Inactivation Through Mutation or Therapeutic Blockade

Clinical infectious diseases, 2019-05, Vol.68 (11), p.1911-1918

2019

Volltextzugriff (PDF)

Immune Activation: A Link Between Food Insecurity and Chronic Disease in People Living With Human Immunodeficiency Virus

The Journal of infectious diseases, 2021-12, Vol.224 (12), p.2043-2052

2021

Volltextzugriff (PDF)

Prevalence of Diagnosed and Undiagnosed Hepatitis C in a Midwestern Urban Emergency Department

Clinical infectious diseases, 2016-05, Vol.62 (9), p.1066-1071

2016

Volltextzugriff (PDF)

HIV Mono-infection Is Associated With FIB-4 — A Noninvasive Index of Liver Fibrosis — in Women

Clinical infectious diseases, 2011-03, Vol.52 (5), p.674-680

2011

Volltextzugriff (PDF)

CD8+ Cell Responses to Hepatitis C Virus (HCV) in the Liver of Persons with HCV-HIV Coinfection versus HCV Monoinfection

The Journal of infectious diseases, 2005-03, Vol.191 (5), p.702-709

2005

Volltextzugriff (PDF)

Hepatitis C Virus Prevalence among Patients Infected with Human Immunodeficiency Virus: A Cross-Sectional Analysis of the US Adult AIDS Clinical Trials Group

Clinical infectious diseases, 2002-03, Vol.34 (6), p.831-837

2002

Volltextzugriff (PDF)

Hepatitis C Virus (HCV) Diversity in HIV-HCV-Coinfected Subjects Initiating Highly Active Antiretroviral Therapy

The Journal of infectious diseases, 2004-04, Vol.189 (8), p.1472-1481

2004

Volltextzugriff (PDF)

Therapeutic Approach to the Treatment-Naive Patient With Hepatitis C Virus Genotype 1 Infection: A Step-by-Step Approach

Clinical infectious diseases, 2012-11, Vol.55 (9), p.1236-1241

2012

Volltextzugriff (PDF)

Incident Hepatitis C Virus Infection among US HIV-Infected Men Enrolled in Clinical Trials

Clinical infectious diseases, 2011-03, Vol.52 (6), p.812-818

2011

Volltextzugriff (PDF)

Prevalence and Changes in Hepatitis C Virus Genotypes among Multitransfused Persons with Hemophilia

The Journal of infectious diseases, 1999-05, Vol.179 (5), p.1062-1069

1999

Volltextzugriff (PDF)

Lack of Association of Hepatitis C Virus Load and Genotype with Risk of End-Stage Liver Disease in Patients with Human Immunodeficiency Virus Coinfection

The Journal of infectious diseases, 2001-11, Vol.184 (9), p.1202-1205

2001

Volltextzugriff (PDF)

Provisional Guidance on the Use of Hepatitis C Virus Protease Inhibitors for Treatment of Hepatitis C in HIV-Infected Persons

Clinical infectious diseases, 2012-04, Vol.54 (7), p.979-983

2012

Volltextzugriff (PDF)

Mechanism of Indinavir-Induced Hyperbilirubinemia

Proceedings of the National Academy of Sciences - PNAS, 2001-10, Vol.98 (22), p.12671-12676

2001

Volltextzugriff (PDF)

Impact of Peginterferon Alpha and Ribavirin Treatment on Lipid Profiles and Insulin Resistance in Hepatitis C Virus/HIV—Coinfected Persons: The AIDS Clinical Trials Group A5178 Study

Clinical infectious diseases, 2012-09, Vol.55 (5), p.631-638

2012

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Aktive Filter

KollektionJSTOR

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(69)

Publikationsform

Artikel
(66)
Reviews
(6)

Sprache

Englisch
(72)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Cost-effectiveness of Screening for Chronic Hepatitis B Infection in the United States

Evolution of Treatment-Emergent Resistant Variants in Telaprevir Phase 3 Clinical Trials

Hepatitis C Virus Coinfection and Superinfection

Nucleoside Analogues and Mitochondrial Toxicity

Hepatitis C Virus Cure Is the Start of the End for Patients With Advanced Fibrosis/Cirrhosis

Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study

Immunogenicity and Safety of Hepatitis B Virus (HBV) Vaccine With a Toll-Like Receptor 9 Agonist Adjuvant in HBV Vaccine-Naïve People With Human Immunodeficiency Virus

Hepatitis C Virus (HCV) Quasispecies Complexity and Selection in HCV/HIV-Coinfected Subjects Treated with Interferon-Based Regimens

Liver Fibrosis Progression and Mortality in Hepatitis B– and C–Coinfected Persons Treated With Directly Acting Antiviral Agents: Results From ERCHIVES

GB Virus C (GBV-C) Infection in Hepatitis C Virus (HCV)/HIV–Coinfected Patients Receiving HCV Treatment: Importance of the GBV-C Genotype

Cost-effectiveness of Screening for Chronic Hepatitis C Infection in the United States

Improvement in Hepatic Fibrosis Biomarkers Associated With Chemokine Receptor Inactivation Through Mutation or Therapeutic Blockade

Immune Activation: A Link Between Food Insecurity and Chronic Disease in People Living With Human Immunodeficiency Virus

Prevalence of Diagnosed and Undiagnosed Hepatitis C in a Midwestern Urban Emergency Department

HIV Mono-infection Is Associated With FIB-4 — A Noninvasive Index of Liver Fibrosis — in Women

CD8+ Cell Responses to Hepatitis C Virus (HCV) in the Liver of Persons with HCV-HIV Coinfection versus HCV Monoinfection

Hepatitis C Virus Prevalence among Patients Infected with Human Immunodeficiency Virus: A Cross-Sectional Analysis of the US Adult AIDS Clinical Trials Group

Hepatitis C Virus (HCV) Diversity in HIV-HCV-Coinfected Subjects Initiating Highly Active Antiretroviral Therapy

Therapeutic Approach to the Treatment-Naive Patient With Hepatitis C Virus Genotype 1 Infection: A Step-by-Step Approach

Incident Hepatitis C Virus Infection among US HIV-Infected Men Enrolled in Clinical Trials

Prevalence and Changes in Hepatitis C Virus Genotypes among Multitransfused Persons with Hemophilia

Lack of Association of Hepatitis C Virus Load and Genotype with Risk of End-Stage Liver Disease in Patients with Human Immunodeficiency Virus Coinfection

Provisional Guidance on the Use of Hepatitis C Virus Protease Inhibitors for Treatment of Hepatitis C in HIV-Infected Persons

Mechanism of Indinavir-Induced Hyperbilirubinemia

Impact of Peginterferon Alpha and Ribavirin Treatment on Lipid Profiles and Insulin Resistance in Hepatitis C Virus/HIV—Coinfected Persons: The AIDS Clinical Trials Group A5178 Study

Aktive Filter

Suchergebnisse filtern